Bridgeway Capital Management’s CME Group CME Stock Holding History

Bridgeway Capital Management’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,500	Closed	-$1.21M	–	1220
2024 Q3	$1.21M	Sell	5,500 -900	-14%	-$186K	0.03%	635
2024 Q2	$1.26M	Sell	6,400 -18,800	-75%	-$3.88M	0.03%	623
2024 Q1	$5.43M	Buy	25,200 +300	+1%	+$63K	0.11%	287
2023 Q4	$5.24M	Sell	24,900 -1,000	-4%	-$213K	0.11%	294
2023 Q3	$5.19M	Sell	25,900 -650	-2%	-$129K	0.13%	267
2023 Q2	$4.92M	Buy	+26,550	New	+$4.91M	0.12%	281
2017 Q3	–	Sell	-369,380	Closed	-$46.3M	–	1405
2017 Q2	$46.3M	Hold	369,380	–	–	0.56%	64
2017 Q1	$43.9M	Buy	369,380 +17,280	+5%	+$2.08M	0.53%	60
2016 Q4	$40.6M	Buy	352,100 +3,500	+1%	+$389K	0.53%	59
2016 Q3	$36.4M	Buy	348,600 +1,400	+0.4%	+$146K	0.54%	56
2016 Q2	$33.8M	Buy	347,200 +186,200	+116%	+$17.6M	0.52%	50
2016 Q1	$15.5M	Buy	+161,000	New	+$14.6M	0.26%	128

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bridgeway Capital Management's CME Position: Q4 2024 in Review

Bridgeway Capital Management sold out of CME Group (CME) in Q4 2024, closing a stake of 5,500 shares — an estimated $1.21M sold.

Bridgeway Capital Management first reported a position in CME in Q1 2016 and held it in 12 quarters. The position peaked at $46.3M in Q2 2017. 1,500 funds tracked by Wall St. Rank hold CME as of Q4 2024.

Bridgeway Capital Management reported no remaining CME Group position as of Q4 2024 after selling out during the quarter.
Bridgeway Capital Management sold 5,500 CME Group shares in Q4 2024, an estimated $1.21M.
Bridgeway Capital Management first reported a position in CME Group in Q1 2016 and held it in 12 quarters.
Bridgeway Capital Management's CME Group position peaked at $46.3M in Q2 2017.
1,500 funds tracked by Wall St. Rank held CME Group as of Q4 2024.

Based on Bridgeway Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.